General Archive

-
News releases
Newborn screening programme a big step forward for rare disease research
The announcement by Genomics England and NHS England on the newborn sequencing programme is a significant step forward in transforming…
-
News releases
Dr Sam Barrell CBE appointed as CEO of LifeArc
LifeArc is pleased to announce the appointment of Dr Sam Barrell, CBE, as Chief Executive Officer. Sam’s appointment follows an…
-
News releases
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
A new £6.2m healthcare project has begun in Kenya to advance elimination of visceral leishmaniasis, a deadly parasitic disease found…
-
News releases
Dr Melanie Lee CBE steps down as CEO of LifeArc
Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer, effective 30 September…
-
Articles & blogs
New Alzheimer’s treatment ‘lecanemab’ approved for use in the US
LifeArc played an instrumental role in the drug’s development through our antibody humanisation work.
-
News releases
LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa
Joint initiative part of LifeArc’s £100 million Translational Challenge to help address rare disease translational science.
-
News releases
New UK-based research project brings together world-leading institutions to transform care for people living with dementia
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures
-
News releases
LifeArc strengthens Board of Trustees with new appointments
Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem join LifeArc’s Board of Trustees as Non-Executive Directors.
-
Articles & blogs
How LifeArc’s Neurodegeneration Translational Challenge is leading the charge against Motor Neurone Disease
June 21st is Global MND Awareness Day, a day to raise worldwide awareness of MND (Motor Neurone Disease) and to…
-
News releases
New programme to move potential MND drugs into clinical trials faster
EXPERTS-ALS to screen candidate drugs at scale and identify those that should be fast-tracked to larger clinical trials
-
News releases
LifeArc and Sarcoma UK fund research to guide treatment decisions in rare cancer
£150,000 grant will fund a study of a biomarker test that could improve outcomes for patients with a rare sarcoma…
-
News releases
LifeArc announces strategic partnership with PrecisionLife as part of its Motor Neuron Disease Translational Challenge
LifeArc and PrecisionLife will work together to select and validate multiple novel targets and their accompanying patient stratification biomarkers.